Practical Geriatrics ›› 2021, Vol. 35 ›› Issue (10): 1036-1039.doi: 10.3969/j.issn.1003-9198.2021.10.010

Previous Articles     Next Articles

Expression of transcription factor activator protein-2a in elderly patients with lung adenocarcinoma and its relationship with clinicopathological parameters

FANG Le-ping, FAN Wei-fei, DONG Zhen   

  1. FANG Le-ping, FAN Wei-fei, Department of Hematology Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing 210024, China;
    DONG Zhen, Department of Radiotherapy, BenQ Medical Center Affiliated to Nanjing Medical University, Nanjing 222023, China
  • Received:2020-11-16 Online:2021-10-20 Published:2021-10-13

Abstract: Objective To investigate the expression of transcription factor activator protein-2a (TFAP-2a) in the elderly patients with lung adenocarcinoma and its relationship with clinicopathological parameters. Methods The difference of TFAP-2a expression between lung adenocarcinoma and normal lung tissue and its effect on the prognosis of lung adenocarcinoma were analyzed by bioinformatics data. A total of 64 cases of elderly lung adenocarcinoma tissue and 25 cases of elderly normal lung tissue were collected from August 2015 to March 2020, and the expression of TFAP-2a was detected by immunohistochemical staining, and the correlation between TFAP-2a expression and clinicopathological parameters was analyzed. Results The GEPIA database analysis results showed that the expression level of TFAP-2a in lung adenocarcinoma tissue was significantly higher than that in normal lung tissue (P<0.05), but there were no significant differences among lung adenocarcinoma tissues with different TNM staging (P>0.05). KMplot database analysis results showed that the progression-free survival and overall survival of the patients with lung adenocarcinoma with low expression of TFAP-2a were better than those with high expression of TFAP-2a (all P<0.05). The immunohistochemical staining results showed that the proportion of high expression of TFAP-2a in the elderly lung adenocarcinoma tissue was significant higher than that in the elderly normal lung tissue (P<0.01), and the proportion of high expression of TFAP-2a in the elderly patients with lung adenocarcinoma who had lymph node metastasis and moderate-low differentiation was higher (P<0.05). Conclusions TFAP-2a is highly expressed in the elderly patients with lung adenocarcinoma. The lung adenocarcinoma with over expression of TFAP-2a is poorer in differentiation and more prone to lymph node metastasis.

Key words: transcription factor activator protein-2a, lung adenocarcinoma, prognosis, bioinformatics

CLC Number: